This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Latin American Network for Respiratory Viruses | |
|---|---|
| Name | Latin American Network for Respiratory Viruses |
| Formation | 21st century |
| Type | Regional surveillance network |
| Location | Latin America and the Caribbean |
| Region served | Latin America, Caribbean |
| Membership | National public health institutes, academic centres, reference laboratories |
Latin American Network for Respiratory Viruses is a regional consortium that coordinates surveillance, laboratory diagnostics, and research on viral respiratory pathogens across Argentina, Brazil, Chile, Colombia, Mexico, Peru, Uruguay, Venezuela and other countries in Central America and the Caribbean. The network connects national reference laboratories, academic institutions, and public health agencies to inform outbreak response for agents such as influenza, respiratory syncytial virus, and novel coronaviruses, while interacting with global entities like the World Health Organization, Pan American Health Organization, and Centers for Disease Control and Prevention. It operates at the intersection of regional health diplomacy exemplified by bodies like the Union of South American Nations and technical cooperation forums such as the Inter-American Development Bank.
The network emerged from regional initiatives following major events including the 2009 flu pandemic, the 2013–2016 Western African Ebola virus epidemic indirect impacts on surveillance priorities, and the COVID-19 pandemic driven by SARS-CoV-2 spread, building on earlier collaborations among institutions such as the Fiocruz, Instituto Nacional de Salud (Colombia), Instituto Nacional de Salud Pública (Mexico), and the Instituto Oswaldo Cruz. Founders drew lessons from multinational responses to outbreaks like the H1N1 influenza outbreak and integrated models from consortia including the Global Influenza Surveillance and Response System and the European Centre for Disease Prevention and Control. Early meetings convened representatives from ministries of health associated with the Mercosur and the Andean Community to harmonize protocols and capacity building.
The network’s mission aligns with mandates of organizations such as the Pan American Health Organization and the World Health Organization to reduce morbidity and mortality from respiratory viruses. Objectives include strengthening sentinel surveillance systems promoted by the Global Health Security Agenda, expanding molecular diagnostic capacity modeled after programs at the Centers for Disease Control and Prevention and Public Health England, and supporting vaccine impact studies like those conducted by the Bill & Melinda Gates Foundation and Gavi, the Vaccine Alliance. It promotes data sharing consistent with frameworks used by the Global Initiative on Sharing All Influenza Data and evidence synthesis similar to outputs from the Cochrane Collaboration.
Membership comprises national public health institutes such as the National Institute of Respiratory Diseases (Mexico), academic centres like the University of São Paulo, and reference laboratories including Instituto Nacional de Salud (Peru). Governance structures incorporate steering committees with representatives drawn from ministries of health engaged in forums such as the Pan American Health Organization Directing Council and technical advisory groups similar to those of the Advisory Committee on Immunization Practices. Funding and oversight have involved multilateral partners like the World Bank, bilateral donors including the United States Agency for International Development, and philanthropic organizations such as the Wellcome Trust.
Surveillance activities integrate sentinel influenza-like-illness and severe acute respiratory infection networks analogous to systems run by the European Centre for Disease Prevention and Control and the Centers for Disease Control and Prevention. The network conducts genomic surveillance informed by initiatives like the COVID-19 Genomics UK Consortium and collaborates on vaccine effectiveness studies employing methods used by the Influenza Vaccine Effectiveness Network (US). Research priorities have included antigenic and genetic characterization of circulating strains, epidemiologic burden assessments mirroring work from the Institute for Health Metrics and Evaluation, and modeling studies informed by groups such as the Imperial College London and the London School of Hygiene & Tropical Medicine.
Laboratory strengthening follows best practices from reference centers such as Fiocruz and Instituto Oswaldo Cruz, with proficiency testing and quality management aligned with ISO 15189 standards. Member laboratories deploy diagnostic platforms including real-time RT-PCR assays validated by the World Health Organization and sequencing technologies similar to those used by the National Institutes of Health (United States). Capacity-building workshops have been hosted in collaboration with academic partners like the University of Buenos Aires and technical training from agencies such as the Centers for Disease Control and Prevention and Pan American Health Organization.
The network partners with international agencies including the World Health Organization, Pan American Health Organization, Centers for Disease Control and Prevention, and research consortia like GISAID; it liaises with regional bodies such as the Organization of American States and the Andean Community. Academic collaborations involve universities including the University of São Paulo, Pontifical Catholic University of Chile, National Autonomous University of Mexico, and global funders like the Bill & Melinda Gates Foundation and the Wellcome Trust. Partnerships extend to private sector diagnostics companies and non-governmental organizations active in outbreak response such as Médecins Sans Frontières.
The network has improved timeliness of outbreak detection in events like seasonal influenza waves and the COVID-19 pandemic, contributing sequence data to repositories used by the World Health Organization and GISAID and informing national vaccination policies in countries including Argentina and Brazil. Its laboratory strengthening efforts have enhanced emergency response capacity after public health emergencies such as the Zika virus epidemic and supported translational research collaborations with institutions like the Oswaldo Cruz Foundation and the Imperial College London. Through training, protocol harmonization, and data sharing, the network has influenced regional public health preparedness initiatives coordinated by the Pan American Health Organization and contributed to policy dialogues at summits like the Summit of the Americas.
Category:Public health organizations Category:Infectious disease surveillance